Empagliflozin Impurity 102 CAS CATO-C4X-1065102
| CAS No. | CATO-C4X-1065102 |
| Molecular Formula | C15H14ClIO |
| Molecular Weight | 372.63 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Empagliflozin Impurity 102 is closely related to a hydroxyl group, an ether linkage, chlorine/iodine substitution, a polycyclic aromatic system in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
Empagliflozin Impurity 102 (CAS CATO-C4X-1065102) is a certified pharmaceutical impurity reference standard with the molecular formula C15H14ClIO and a molecular weight of 372.63 g/mol.
Owing to a hydroxyl group, an ether linkage, chlorine/iodine substitution, a polycyclic aromatic system, Empagliflozin Impurity 102 is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 372.63 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
As a certified reference material (CRM), Empagliflozin Impurity 102 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C15H14ClIO |
| Molecular Weight | 372.63 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl/I-containing |
Related Empagliflozin Standards
- Empagliflozin impurity 208 (CAS CATO-C4X-1065208)
- Empagliflozin impurity 242 (CAS CATO-C4X-1065242)
- Empagliflozin impurity 246 (CAS CATO-C4X-1065246)
- Empagliflozin impurity 251 (CAS CATO-C4X-1065251)
- Empagliflozin Impurity 80 (CAS CATO-C4X-106580)
- Empagliflozin Impurity 81 (CAS CATO-C4X-106581)
- Empagliflozin Impurity 305 (CAS CATO-C4X-1065305)
- Empagliflozin Impurity 146 (CAS CATO-C4X-1065146)
Recommended Standards
- 1-(2-bromophenyl)-N-methyl-2-propanamine 1-(2-bromophenyl)-N-methyl-propan-2-amine 466-37-5 A827086 (CAS 466-37-5)
- N-(4-Chlorobenzoyl)-2-(2,4-dichlorophenoxy)ethanehydrazonamide (CAS 338395-78-1)
- Dapagliflozin Impurity 127 (CAS CATO-C4X-1138127)
- 4-Chlorophenyl 3-{[(3,4-dichlorobenzyl)oxy]imino}propanoate (CAS 338395-25-8)
- Ozenoxacin Impurity 56 (CAS CATO-C4X-279656)
- Apixaban Impurity 118 (CAS 2818923-97-4)
- Naltrexone EP Impurity E (CAS 767615-69-0)
- Rubidium hydroxide hydrate (CAS 12026-05-0)
- 2-Bromo-3-chloro-4-methyl-6-nitroaniline (CAS 1291492-45-9)
- 4-Methyl-N-(2-methylbenzyl)benzamide (CAS 331638-64-3)
- [2-Amino-1-(4-bromophenyl)ethyl]dimethylamine (CAS 951917-39-8)
- n-[(4-methylmorpholin-2-yl)methyl]-1,3-thiazol-2-amine (CAS 1423035-13-5)
- 2-(5-Bromopyrimidin-2-yl)ethanamine (CAS 914394-80-2)
- Biotinyl-S6 Phosphate Acceptor Peptide trifluoroacetate salt (CAS 1815618-12-2)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com